国产午夜福利片1000无码丨人妻国产成人久久av免费高清丨午夜做受视频试看6次丨日韩av不卡一区在线免费观看丨在线观看精品三级欧美

Your Good Partner in Biology Research

  1. Home
  2. 抗體
  3. 重組抗體
  4. SLC39A6 monoclonal antibody

SLC39A6 monoclonal antibody

  • 中文名稱(chēng)：
    SLC39A6重組抗體
  • 貨號(hào)：
    CSB-RA621669MA1HU
  • 規(guī)格：
    ￥1320
  • 圖片：
    • The Binding Activity of SLC39A6 with anti-SLC39A6 antibody
      Activity: Measured by its binding ability in a functional ELISA. Immobilized Human SLC39A6(CSB-BP621669HU) at 1 μg/ml can bind Anti-SLC39A6-1 recombinant antibody, the EC50 is 0.6873-0.9010 ng/mL.
    • The Binding Activity of Cynomolgus SLC39A6 with Anti-SLC39A6 Recombinant Antibody
      Activity: Measured by its binding ability in a functional ELISA. Immobilized Cynomolgus SLC39A6 (CSB-BP5043MOV) at 2 μg/mL can bind Anti-SLC39A6 recombinant antibody. The EC50 is 0.8290-0.9864 ng/mL.
  • 其他：

產(chǎn)品詳情

  • 產(chǎn)品描述：
    CSB-RA621669MA1HU SLC39A6重組單克隆抗體是針對(duì)鋅轉(zhuǎn)運(yùn)蛋白家族成員SLC39A6/ZIP6開(kāi)發(fā)的高特異性科研試劑。該蛋白作為跨膜鋅離子轉(zhuǎn)運(yùn)體，參與調(diào)控細(xì)胞內(nèi)鋅離子穩(wěn)態(tài)，在細(xì)胞增殖、分化及腫瘤發(fā)生發(fā)展中具有潛在調(diào)控作用。本產(chǎn)品經(jīng)ELISA平臺(tái)嚴(yán)格驗(yàn)證，展現(xiàn)出優(yōu)異的抗原結(jié)合能力與檢測(cè)靈敏度，其重組單克隆抗體特性確保批次間高度一致性，滿足定量分析與重復(fù)性實(shí)驗(yàn)需求。該抗體適用于基礎(chǔ)科研中探索SLC39A6在腫瘤微環(huán)境、上皮間質(zhì)轉(zhuǎn)化（EMT）等生理病理過(guò)程中的分子機(jī)制，可配合體外培養(yǎng)細(xì)胞模型或組織樣本進(jìn)行蛋白表達(dá)水平分析，為鋅代謝相關(guān)信號(hào)通路研究提供可靠工具。建議配合陽(yáng)性對(duì)照樣本以優(yōu)化實(shí)驗(yàn)條件，適用于細(xì)胞裂解液、重組蛋白等樣本類(lèi)型的檢測(cè)需求。
  • Uniprot No.：
  • 基因名：
  • 別名：
    SLC39A6 monoclonal antibody
  • 反應(yīng)種屬：
    Human, Macaca fascicularis
  • 免疫原：
    Recombinant Human SLC39A6 protein
  • 免疫原種屬：
    Homo sapiens (Human)
  • 標(biāo)記方式：
    Non-conjugated
  • 克隆類(lèi)型：
    Monoclonal
  • 抗體亞型：
    hIgG1
  • 純化方式：
    Affinity-chromatography
  • 克隆號(hào)：
    13F1
  • 濃度：
    It differs from different batches. Please contact us to confirm it.
  • 保存緩沖液：
    Preservative: 0.03% Proclin 300
    Constituents: 50% Glycerol, 0.01M PBS, PH 7.4
  • 產(chǎn)品提供形式：
    Liquid
  • 應(yīng)用范圍：
    ELISA
  • Protocols：
  • 儲(chǔ)存條件：
    Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
  • 貨期：
    Basically, we can dispatch the products out in 1-3 working days after receiving your orders. Delivery time maybe differs from different purchasing way or location, please kindly consult your local distributors for specific delivery time.
  • 用途：
    For Research Use Only. Not for use in diagnostic or therapeutic procedures.

產(chǎn)品評(píng)價(jià)

靶點(diǎn)詳情

  • 功能：
    May act as a zinc-influx transporter.
  • 基因功能參考文獻(xiàn)：
    1. ZIP6 deficiency disturbs intracellular Zn2+ homeostasis, leading to increased cell survival in hypoxia and reduced E-cadherin expression, indicating that decreased ZIP6 expression is strongly associated with resistance to hypoxia. PMID: 28833062
    2. SLC39A6 promotes aggressiveness of esophageal carcinoma cells by increasing intracellular levels of zinc, activating phosphatidylinositol 3-kinase signaling, and up-regulating genes that regulate metastasis. PMID: 28209530
    3. Upregulation of SLC39A6 is associated with hepatocellular carcinoma. PMID: 26684241
    4. SLC39A6 may have a tumor promoting role in esophageal carcinoma PMID: 26444413
    5. Knock-down of ZIP6 but not ZIP7 in MIN6 beta cells impaired the protective effects of GLP-1 on fatty acid-induced cell apoptosis, possibly via reduced activation of the p-ERK pathway PMID: 25969539
    6. drug resistance of ovarian cancer cells to trichostatin A may be related to expression of the LIV1 gene PMID: 25420545
    7. Zinc and its transporters, ZIP6 and ZIP10, are required for the breast cancer cells motility stimulated with high glucose level, such as in diabetes. PMID: 24587242
    8. a causative role for ZIP6 in cell motility and migration PMID: 23919497
    9. Down-regulated LIV-1 cells showed significant inhibition of proliferation in vitro and reduction of tumor growth in vivo. Furthermore, E-cadherin expression increased in LIV-1 siRNA expressing Hep-G2. PMID: 23437163
    10. SLC39A6 has an important role in the prognosis of esophageal squamous-cell carcinoma and may be a potential therapeutic target. PMID: 23644492
    11. Some studies correlate LIV-1 expression with a more aggressive cancer phenotype and increased likelihood for metastasis to lymph nodes. In contrast, other evidence suggests this transporter is associated with a more favorable prognosis. [review] PMID: 22852056
    12. The results of this study showed evidence for a positive correlation between LIV1 and ZnT6 insuperior temporal, occipital, and frontal gyri in patient with alzheimer disease. PMID: 22349685
    13. LIV-1 is involved in prostate cancer progression as an intracellular target of growth factor receptor signaling which promoted EMT and cancer metastasis PMID: 22110740
    14. LIV-1 mRNA upregulation is associated with the progression of cervical cancer but not with the development of endometrial carcinoma. PMID: 17959546
    15. The present study identifies LIV1 as a critical mediator responsible for HDACi-induced apoptosis. The effect of LIV1 is, at least in part, mediated by affecting intracellular zinc homeostasis. PMID: 19887557
    16. Zip6 over-expression is not an underlying mechanism initiating breast cancer, but in fact may play a "tumor-constraining" role. PMID: 19852955
    17. Structure-function analysis of LIV-1. PMID: 12839489
    18. data suggest that LIV-1 protein is a promising candidate for a novel marker for breast cancer patients with better outcome PMID: 15986450
    19. regulation of LIV-1 protein in human breast cancer xenografts PMID: 17786585
    20. Hence, our data provide the first evidence that LIV-1 mRNA is overexpressed in cervical cancer in situ and is involved in invasion of cervical cancer cells through targeting MAPK-mediated Snail and Slug expression. PMID: 17825787
    21. LIV-1 may be a regulator of E-cadherin PMID: 18330719
    22. Single nucleotide polymorphism in SLC39A6 gene is associated with acute lymphoblastic leukemia. PMID: 19066393
    23. LIV-1 enhances the aggressive phenotype through the induction of epithelial to mesenchymal transition in human pancreatic carcinoma cells. PMID: 19724917
    24. LIV-1 co-clusters with estrogen receptor alpha in microarray analysis of breast cancer biopsies. PMID: 11911440
    25. Review of LIV-1 and other LZT proteins. PMID: 12659941
    26. LIV-1, a member of the ZIP family of zinc transporters, is an integral plasma membrane protein that transports zinc into cells. PMID: 12839489
    27. LIV-1 is coregulated with estrogen receptor in some breast cancers. PMID: 12960427

    顯示更多

    收起更多

  • 亞細(xì)胞定位：
    Cell membrane; Multi-pass membrane protein.
  • 蛋白家族：
    ZIP transporter (TC 2.A.5) family
  • 組織特異性：
    Highly expressed in the breast, prostate, placenta, kidney, pituitary and corpus callosum. Weakly expressed in heart and intestine. Also highly expressed in cells derived from an adenocarcinoma of the cervix and lung carcinoma.
  • 數(shù)據(jù)庫(kù)鏈接：

    HGNC: 18607

    OMIM: 608731

    KEGG: hsa:25800

    STRING: 9606.ENSP00000269187

    UniGene: Hs.79136



主站蜘蛛池模板： 宁德市| 敦化市| 博白县| 临桂县| 仁化县| 临朐县| 唐山市| 诸城市| 准格尔旗| 涪陵区| 龙门县| 周至县| 乐都县| 保定市| 攀枝花市| 云龙县| 江西省| 德保县| 丰原市| 五莲县| 嘉义县| 陕西省| 乌兰浩特市| 岢岚县| 大余县| 潮州市| 津市市| 榆社县| 兰西县| 乌海市| 巴青县| 教育| 沙坪坝区| 大连市| 永定县| 蚌埠市| 龙南县| 大石桥市| 博兴县| 宁城县| 富裕县|